KR
Insider selling
Kristian Reich sold $22K of MLTX stock
Kristian Reich, Chief Scientific Officer of MoonLake Immunotherapeutics (MLTX), sold 1,100 shares of MLTX stock worth $22K, per an SEC Form 4 filed Jul 29, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 27, 2026, 2 days before it was made public.
MLTX has moved -40.4% since the trade date, from $19.88 to $11.85 (Oct 23, 2026 close).
- Traded
- Jul 27, 2026
- Disclosed
- Jul 29, 2026
- Filing delay
- 2 days
- Price since
- -40.4%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More MLTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.